
Takeda has unveiled exploratory data on its gut-selective biologic drug Entyvio (vedolizumab) at the 2019 Digestive Disease Week, demonstrating its …
Scots neonatal innovations target hearing loss and earlier care
Long-acting therapies set to reshape HIV treatment market

